Businessweek Archives

The High Price Of Bad Blood


CORRECTIONS & CLARIFICATIONS

The high price of bad blood

"The high price of bad blood" (Top of the News, Sept. 27) stated that the National Hemophilia Foundation was demanding a settlement from Baxter International Inc. and three other suppliers to compensate hemophiliacs who contracted AIDS through clotting agents. The group is targeting four other suppliers besides Baxter.


Tim Cook's Reboot
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus